BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 28487465)

  • 1. Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?
    Antonio M; Saldaña J; Carmona-Bayonas A; Navarro V; Tebé C; Nadal M; Formiga F; Salazar R; Borràs JM
    Oncologist; 2017 Aug; 22(8):934-943. PubMed ID: 28487465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Predicting Adherence to a Tailored-Dose Adjuvant Treatment on the Basis of Geriatric Assessment in Elderly People With Colorectal Cancer: A Prospective Study.
    Antonio M; Carmona-Bayonas A; Saldaña J; Navarro V; Tebé C; Salazar R; Borràs JM
    Clin Colorectal Cancer; 2018 Mar; 17(1):e59-e68. PubMed ID: 29054805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
    Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
    BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for colorectal cancer in the elderly.
    Kim JH
    World J Gastroenterol; 2015 May; 21(17):5158-66. PubMed ID: 25954089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxicity Outcomes in a Population-based Cohort of Elderly Patients Treated With Adjuvant Oxaliplatin for Colorectal Cancer.
    Raphael MJ; Fischer HD; Fung K; Austin PC; Anderson GM; Booth CM; Singh S
    Clin Colorectal Cancer; 2017 Dec; 16(4):397-404.e1. PubMed ID: 28434884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer.
    Antonio M; Saldaña J; Linares J; Ruffinelli JC; Palmero R; Navarro A; Arnaiz MD; Brao I; Aso S; Padrones S; Navarro V; González-Barboteo J; Borràs JM; Cardenal F; Nadal E
    Br J Cancer; 2018 Mar; 118(5):639-647. PubMed ID: 29381689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals.
    Barthélémy P; Heitz D; Mathelin C; Polesi H; Asmane I; Litique V; Rob L; Bergerat JP; Kurtz JE
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):196-204. PubMed ID: 20655243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy.
    Tucci A; Ferrari S; Bottelli C; Borlenghi E; Drera M; Rossi G
    Cancer; 2009 Oct; 115(19):4547-53. PubMed ID: 19562776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer in the elderly: is palliative chemotherapy of value?
    Honecker F; Köhne CH; Bokemeyer C
    Drugs Aging; 2003; 20(1):1-11. PubMed ID: 12513112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early breast cancer in the elderly: assessment and management considerations.
    Albrand G; Terret C
    Drugs Aging; 2008; 25(1):35-45. PubMed ID: 18184027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
    Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
    Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre study.
    Yamano T; Yamauchi S; Kimura K; Babaya A; Hamanaka M; Kobayashi M; Fukumoto M; Tsukamoto K; Noda M; Tomita N; Sugihara K;
    Eur J Cancer; 2017 Aug; 81():90-101. PubMed ID: 28622612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy in elderly patients with breast cancer: key challenges.
    Pondé N; Dal Lago L; Azim HA
    Expert Rev Anticancer Ther; 2016 Jun; 16(6):661-71. PubMed ID: 27010772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frailty status but not age predicts complications in elderly cancer patients: a follow-up study.
    Ørum M; Gregersen M; Jensen K; Meldgaard P; Damsgaard EMS
    Acta Oncol; 2018 Nov; 57(11):1458-1466. PubMed ID: 30280625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
    Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
    Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity.
    Lemmens VE; van Halteren AH; Janssen-Heijnen ML; Vreugdenhil G; Repelaer van Driel OJ; Coebergh JW
    Ann Oncol; 2005 May; 16(5):767-72. PubMed ID: 15817594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial.
    He Y; Liu P; Zhang Y; Deng X; Meng W; Wei M; Yang T; Wang Z; Qiu M
    Trials; 2015 May; 16():238. PubMed ID: 26021722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.